Primary Tumor Research and Outcomes Network

Recruiting now

Conditions studied: Spinal Column Tumor

In brief

This project aims to establish a network of spine oncology centers dedicated to prospective multicenter research of patients diagnosed with a primary tumor of the spine and will include a comprehensive prospective clinical database which will serve as a shared research platform. Demographic, clinical, diagnostic, and therapeutic variables will be used to answer questions about survival and local recurrence, as well as questions about adverse events (AEs), morbidity data, and health-related quality of life (HRQOL) outcomes.

Key facts

Study ID

NCT02790983

Run by

AO Innovation Translation Center

People needed

1350

Starts

2016-10-01

Expected to finish

2028-12-01

Last updated by the study team

2026-02-25

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient with a current primary spine tumor or history of a primary spine tumor, including tumors within or surrounding the spinal column and/or spinal cord. This includes extradural tumors, intramedullary tumors (i.e. astrocytomas, ependymoma, etc.) and extramedullary tumors (i.e. meningiomas, neurofibromas, schwannomas, etc.).
• Informed consent obtained, i.e.:
• Ability to understand the content of the patient information/ICF
• Willingness and ability to participate in the registry according to the Registry Plan (RP)
• Signed and dated EC/IRB approved written informed consent
• OR
• Written consent provided according to the IRB/EC defined and approved procedures for patients who are not able to provide independent written informed consent

You may not qualify if…

• Patient diagnosed with a metastatic tumor of the spine.

Where it is running

• National Center for Spinal Disorders and Buda Health Center — Budapest, Hungary (enrolling)
• Istituto Ortopedico Rizzoli — Bologna, Italy (enrolling)
• IRCCS Istituto Ortopedico Galeazzi — Milan, Italy (enrolling)
• Mayo Clinic — Rochester, Minnesota, United States (enrolling)
• Oxford University Hospitals — Oxford, United Kingdom (enrolling)
• UCSF Medical Center — San Francisco, California, United States (enrolling)
• Memorial Sloan Kettering Cancer Center — New York, New York, United States (enrolling)
• Rhode Island Hospital — Providence, Rhode Island, United States (enrolling)
• The University of Texas M.D. Anderson Cancer Center — Houston, Texas, United States (enrolling)
• Johns Hopkins University School of Medicine — Baltimore, Maryland, United States (enrolling)
• Vancouver General Hospital and the University of British Columbia — Vancouver, British Columbia, Canada (enrolling)
• Massachusetts General Hospital — Boston, Massachusetts, United States (enrolling)
• Peking University 3rd Hospital — Beijing, Beijing Municipality, China (enrolling)
• Universitaetsklinikum Carl Gustav Carus der Techn. Universitaet - Dresden — Dresden, Germany (enrolling)
• University of Queensland, School of Medicine — Brisbane, Australia
• Memorial Sloan-Kettering Cancer Center — New York, New York, United States
• University of California — Los Angeles, California, United States
• Toronto Western Hospital — Toronto, Ontario, Canada
• Kanazawa Medical University Hospital — Kanazawa, Japan

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.